These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29671500)

  • 1. Qvar for Treatment of Chronic Asthma.
    Jayanth A
    Am Fam Physician; 2018 Apr; 97(8):538-539. PubMed ID: 29671500
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and safety of beclomethasone dipropionate HFA.].
    Capristo C; Rossi GA
    Recenti Prog Med; 2017 Nov; 108(11):1-11. PubMed ID: 29255325
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children.
    van Schayck CP; Donnell D
    Int J Clin Pract; 2004 Aug; 58(8):786-94. PubMed ID: 15372852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A; Richter A; Oster H; Criée CP
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C; Guerriero M; Tognella S; Dal Negro RW
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress of research on pressurized metered dose inhalers].
    Zhou X
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147
    [No Abstract]   [Full Text] [Related]  

  • 8. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
    Lipworth BJ; Jackson CM
    Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427
    [No Abstract]   [Full Text] [Related]  

  • 9. Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.
    Leach CL; Kuehl PJ; Chand R; McDonald JD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):127-33. PubMed ID: 26061801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corticoid therapy in asthma. Smaller particles--bigger effect].
    MMW Fortschr Med; 2004 Mar; 146(13):63. PubMed ID: 15219141
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrafine aerosols and peripheral airway function in asthma.
    Merkus PJ; Gappa M; Janssens H; Pijnenburg MW
    Pediatr Pulmonol; 2012 Jun; 47(6):626; author reply 627. PubMed ID: 22081582
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.
    Derom E; Pauwels RA
    Clin Pharmacokinet; 2005; 44(8):815-36. PubMed ID: 16029067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchial asthma showing reduction in FEV1 after inhalation of Qvar.
    Nobata K; Fujimura M; Myou S; Ishiura Y; Mizuguchi M; Nishi K; Nakao S
    J Asthma; 2006 Aug; 43(6):427-8. PubMed ID: 16952859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchial asthma. Small bronchi are not spared].
    MMW Fortschr Med; 2002 May; 144(18):64. PubMed ID: 12422715
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is inhaled beclomethasone (BDP) with a non-CFC propellant equivalent to the CFC propellant formulations?
    Chrystyn H
    Respir Med; 2000 Feb; 94(2):177-9; author reply 179-80. PubMed ID: 10714428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.